What Happened Before 23andMe Lost 99.8% of Its Value?

23andMe promised to tell you where you came from. Now, it's not clear where your genetic data is going. With a Chapter 11 filing, a 99.8 percent drop in market value and its founder stepping down to bid on what’s left, the fall of this one-time biotech unicorn is a case study in platform hubris, data monetization and the fatal flaw of a one-time-use business model.